0001493152-24-047496.txt : 20241122 0001493152-24-047496.hdr.sgml : 20241122 20241122172848 ACCESSION NUMBER: 0001493152-24-047496 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241122 DATE AS OF CHANGE: 20241122 EFFECTIVENESS DATE: 20241122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530306 FILM NUMBER: 241491059 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 D 1 primary_doc.xml X0708 D LIVE 0001460702 Qualigen Therapeutics, Inc. 5857 OWENS AVENUE, SUITE 300, CARLSBAD, CA CALIFORNIA 92008 (760) 452-8111 DELAWARE None RITTER PHARMACEUTICALS INC Corporation true Kevin Richardson II 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Executive Officer Interim Chief Executive Officer and Chief Financial Officer Robert Lim 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Director Cody Price 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Director Campbell Becher 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Director Braeden Lichti 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Director Graydon Bensler 5857 Owens Avenue, Suite 300, Carlsbad, CA CALIFORNIA 92008 Director Biotechnology Decline to Disclose 06b false 2024-11-18 false true false 0 Univest Securities LLC 000036105 None None 75 ROCKEFELLER PLAZA SUITE 1838 NEW YORK NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA IL ILLINOIS NE NEBRASKA NJ NEW JERSEY NV NEVADA NY NEW YORK PA PENNSYLVANIA true 5100000 5100000 0 true 33 408000 0 0 false Qualigen Therapeutics, Inc. /s/ Kevin Richardson II Kevin Richardson II Interim Chief Executive Officer and Chief Financial Officer 2024-11-22